entity

Regulation

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Regulation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections

30Hypotheses

0Analyses

1Outgoing

0Incoming

20Experiments

0Debates

No AI portrait yet

Wiki Pages (18)

Knowledge base pages for this entity

Outgoing (1)

Target	Relation	Type	Str
Lysosome Quality Control	involved_in	pathway	0.85

Incoming (0)

Source	Relation	Type	Str
No incoming edges

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
TREM2 Deficiency Drives Microglial Senescence via Lipid Meta	0.836	neurodegeneration	What molecular mechanisms drive microgli
SIRT1 Activation Couples Mitochondrial Biogenesis to Ferropt	0.824	neurodegeneration	View
SASP-Driven Aquaporin-4 Dysregulation	0.782	neurodegeneration	Senolytic therapy for age-related neurod
Cell-Type Specific TREM2 Upregulation in DAM Microglia	0.761	Alzheimer's Disease	SEA-AD Gene Expression Profiling — Allen
MEF2C-Dependent Synaptic Gene Regulation	0.740	neurodegeneration	What molecular mechanisms mediate HDAC9'

SMPD1 (Acid Sphingomyelinase) Inhibition for Ceramide Reduct	0.732	neurodegeneration	How do sphingomyelin/ceramide ratios spe
SCFA Deficiency Drives Microglial Hyperactivation via GPR43/	0.728	neurodegeneration	How does gut microbiome dysbiosis contri
Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat	0.705	neurodegeneration	Perivascular spaces and glymphatic clear
GluN2B Tonic Activity Suppresses Glymphatic Perfusion Via Va	0.700	neuroscience	GluN2B-Mediated Thalamocortical Control
AQP4 Dysregulation Promotes Neuroinflammation Through Impair	0.680	neurodegeneration	What are the specific molecular mechanis
DRP1 S616 Hyperphosphorylation and MFN2 Downregulation Creat	0.680	neurodegeneration	-
TFEB-mediated transcriptional upregulation of lysosomal gene	0.679	neuroscience	Lysosomal dysfunction and cathepsin leak
Excitatory Neuron Vulnerability via SLC17A7 Downregulation	0.675	Alzheimer's Disease	SEA-AD Gene Expression Profiling — Allen
TREM2-Mediated Cholesterol Dysregulation in Microglial Senes	0.666	neurodegeneration	Gene expression changes in aging mouse b
LRRK2 Volume Sensor Hijacking Drives Metabolic Dysregulation	0.666	neurodegeneration	Does LRRK2's role as a lysosomal volume
Gamma entrainment corrects AD-related clock gene dysregulati	0.651	Alzheimer's disease	Gamma entrainment therapy to restore hip
Endothelial miR-181c-5p Upregulation Drives Claudin-5 Repres	0.645	-	What blood-brain barrier permeability ch
Neuronal TET1 Upregulation Reactivates Immediate-Early Genes	0.640	neurodegeneration	epigenetic reprogramming aging neurons
Microglial TREM2 downregulation impairs damage-associated re	0.626	Alzheimer's disease	SEA-AD Single-Cell Analysis: Cell-Type V
RNA-Binding Protein Sequestration and 3′UTR Dysregulation	0.625	-	How does the intron-retained RNA isoform
C1Q-Induced Foam Cell Formation via Scavenger Receptor Upreg	0.620	neuroinflammation	What are the specific molecular mechanis
Synaptic RNA Metabolism Dysregulation	0.620	neurodegeneration	What mechanisms underlie TDP-43's contri
Nuclear TDP-43 Depletion Drives Synaptic Splicing Dysregulat	0.620	neurodegeneration	Gap 006 analysis (archived stub)
PDGF-BB/PDGFRβ/STAT3 Paracrine Signaling Axis Mediates Aβ-In	0.618	neurodegeneration	How do perivascular cells specifically r
Complement-Mediated Synaptic Pruning Dysregulation	0.612	neurodegeneration	Gene expression changes in aging mouse b
Age-Accelerated miR-155 Upregulation Primes Nigral Microglia	0.610	neuroinflammation	How do regional, age, and sex-dependent
Optogenetic PV Cell Activation Restores Gamma Power via PV P	0.610	Alzheimer's disease	Closed-loop optogenetic targeting PV int
APOE4 lipid dysregulation and synaptic phagocytosis as early	0.604	neurodegeneration	AD Master Plan preregistration: APOE
Aβ-induced downregulation of circPDS5B derepresses TDP-43 mR	0.595	neurodegeneration	What mechanisms drive TDP-43 pathology s
LAMP2A Upregulation to Enhance Chaperone-Mediated Autophagy	0.000	proteomics	Quantitative proteomics of the aging syn

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (20)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Anti-ASC antibody intracerebroventricular injection in APP/PS1 mice	validation	Alzheimer's disease	0.950	0.00	APP/PS1 transgenic mice (8 mon	proposed	N/A
Curcumin-Licorice Combination in D-galactose/Sodium Nitrite AD Model	validation	Alzheimer's disease	0.950	0.00	C57BL/6 mice	proposed	N/A
Irisin effects on osteogenic differentiation in mesenchymal stem cells	exploratory	bone fracture	0.900	0.00	mouse bone mesenchymal stem ce	proposed	N/A
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Co	clinical	Alzheimer's Disease	0.900	0.50	aortic endothelial cells	proposed	$6,550,000
SPP1 upregulation in perivascular cells in AD mouse models	exploratory	Alzheimer's disease	0.900	0.00	AD mouse models	proposed	N/A
Tet2 modulation in Aβ42-injured mouse hippocampal neurons	exploratory	Alzheimer's disease	0.900	0.00	primary mouse hippocampal neur	proposed	N/A
AAV-mediated Tet2 modulation in 2×Tg-AD mice behavioral study	validation	Alzheimer's disease	0.900	0.00	young APPswe/PSEN1 double-tran	proposed	N/A
Cerebrovascular function analysis in CD2AP mutant mice	validation	Alzheimer's disease	0.900	0.00	mice	proposed	N/A
Cerebral blood flow regulation in CD2AP mutant mice	validation	Alzheimer's disease	0.880	0.00	mice	proposed	N/A
Abeta-induced cell death and aggregation in GD3S-deficient neurons	exploratory	Alzheimer's disease	0.850	0.00	primary neurons and astrocytes	proposed	N/A
Generation of Aβ-specific Tregs using CRISPR-Cas9	exploratory	Alzheimer's disease	0.850	0.00	engineered Tregs	proposed	N/A
Cell-cell interaction analysis of perivascular-microglial crosstalk	exploratory	Alzheimer's disease	0.800	0.00	AD mouse models	proposed	N/A
Activity-dependent PGC-1α transcriptional program analysis	exploratory	neurodevelopmental disorders	0.800	0.00	mouse cortical neurons	proposed	N/A
Proposed experiment from debate on Perivascular spaces and glymphatic	falsification	Neurodegeneration	0.400	0.50	mouse	proposed	$240,000
s:** - Test tau spreading in AQP4 knockout vs wild-type mice with PSP/	falsification	Neurodegeneration	0.400	0.50	mouse	proposed	$260,000
Proposed experiment from debate on Perivascular spaces and glymphatic	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$100,000
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Co	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
NPH Glymphatic System Interaction Experiment	clinical	Neurodegeneration	0.400	0.50	human	proposed	$5,460,000
Vascular Contributions to Alzheimer Disease and Mixed Pathology	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Transcriptomic cytoarchitecture reveals principles of human neocortex organizati [PMID:37824655]	Jorstad NL, Close J, Johansen N, Yanny A	Science	2023	186
Integrated multimodal cell atlas of Alzheimer’s disease [PMID:37292694]	Gabitto MI, Travaglini KJ, Rachleff VM,	Research Square	2023	63
Aquaporin-4 in glymphatic system, and its implication for central nervous system [PMID:36796590]	Peng S, Liu J, Liang C, Yang L, Wang G	Neurobiol Dis	2023	2
Uncommon inflammatory/immune-related myelopathies. [PMID:34715593]	Valencia-Sanchez C, Flanagan EP	J Neuroimmunol	2021	2
NETs induce ferroptosis of endothelial cells in LPS-ALI through SDC-1/HS and dow [PMID:38677244]	Fei Y, Huang X, Ning F, Qian T, Cui J, W	Biomed Pharmacother	2024	1
Protectin conjugates in tissue regeneration 1 restores lipopolysaccharide-induce [PMID:34217286]	Wang XY, Li XY, Wu CH, Hao Y, Fu PH, Mei	Respir Res	2021	1
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797]	Zhou Y, Song WM, Andhey PS, Swain A, Lev	Nat Med	2020	1
Glymphatic System Impairment in Alzheimer's Disease and Idiopathic Normal Pressu [PMID:31959516]	Reeves BC, Karimy JK, Kundishora AJ, Mes	Trends Mol Med	2020	1
Inebilizumab-cdon. [PMID:32936251]	Unknown	American journal of health-sys	2020	1
The glycocalyx: a novel diagnostic and therapeutic target in sepsis. [PMID:30654825]	Uchimido R, Schmidt EP, Shapiro NI	Crit Care	2019	1
The glymphatic pathway in neurological disorders. [PMID:30353860]	Rasmussen MK, Mestre H, Nedergaard M	Lancet Neurol	2018	1
Pathogenic Variants and Olipudase Alfa Treatment of Patients With Acid Sphingomy [PMID:41692468]	["Hsu-Heng Lin", "Hui-An Chen", "Shyh-Je	Molecular genetics & genom	2026	0
Multi-omics analysis identifies SMPD1 as a key contributor in sphingolipid pathw [PMID:41428198]	["Aron Park", "Baeki E Kang", "Eun-Ju Ji	Genes & genomics	2026	0
Moderate Effects of the Arginine to Histidine R47H Variant of the Triggering Rec [PMID:41890852]	["Ramirez G", "Hernandez D", "Teal A", "	Research square	2026	0
Increased plasma soluble TREM2 levels in non-Alzheimer's dementia. [PMID:41920402]	Güven Gamze; Gezegen Haşim; &	Acta neurologica Belgica	2026	0
Pathogenic Significance of Serum Syndecan-1 and Syndecan-4 in Psoriasis. [PMID:41839009]	Yıldırım MA, Korkmaz S, Çelik HHA, Büyük	Cutis	2026	0
A multi-dimensional bioinformatic dissection of the molecular mechanisms in high [PMID:41191606]	Yu X MD, Lei J MSc, Du X MSc, He Y MSc,	Int J Surg	2026	0
Plasma metabolites may inhibit childhood obesity by regulating ferroptosis throu [PMID:41249848]	Wang JG, Pan XH, Li Y	Int J Obes (Lond)	2026	0
Renin inhibition improved muscular function by alleviating insulin resistance an [PMID:41391695]	Zhang QY, Ding F, Qin XH, Guo YX, Liu Q	Biochem Pharmacol	2026	0
Multi-omics analysis identifies SMPD1 as a key contributor in sphingolipid pathw [PMID:41428198]	Park A, Kang BE, Jin EJ, Kim HJ, Lee CW	Genes Genomics	2026	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning Regulation in their description or question text

SMPD1 (Acid Sphingomyelinase) Inhibition for Ceramide Reduction and BACE1 Regula

Score: 0.732 · neurodegeneration · 2026-04-16

**Molecular Mechanism and Rationale** The molecular foundation for SMPD1 inhibition in Alzheimer's disease centers on t

SCFA Deficiency Drives Microglial Hyperactivation via GPR43/NF-κB Dysregulation

Score: 0.728 · neurodegeneration · 2026-04-26

Gut dysbiosis depletes butyrate-producing commensals (Faecalibacterium prausnitzii, Clostridium XIVa, Akkermansia mucini

Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulation

Score: 0.705 · neurodegeneration · 2026-04-02

## Mechanistic Overview Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulation starts from the claim that modul

GluN2B Tonic Activity Suppresses Glymphatic Perfusion Via Vasomotion Dysregulati

Score: 0.700 · neuroscience · 2026-04-28

REVISED MECHANISM (post-Skeptic critique): Constitutive GluN2B signaling combined with age-related oxidative stress lead

AQP4 Dysregulation Promotes Neuroinflammation Through Impaired CNS-Peripheral Im

Score: 0.680 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The molecular mechanism underlying AQP4-mediated neuroinflammation centers on the

TFEB-mediated transcriptional upregulation of lysosomal genes as a therapeutic s

Score: 0.679 · neuroscience · 2026-04-22

**Molecular Mechanism and Rationale** The transcription factor EB (TFEB) represents a master regulatory node in cellula

Excitatory Neuron Vulnerability via SLC17A7 Downregulation

Score: 0.675 · Alzheimer's Disease · 2026-04-02

## Mechanistic Overview Excitatory Neuron Vulnerability via SLC17A7 Downregulation starts from the claim that modulating

TREM2-Mediated Cholesterol Dysregulation in Microglial Senescence

Score: 0.666 · neurodegeneration · 2026-04-07

## Mechanistic Overview TREM2-Mediated Cholesterol Dysregulation in Microglial Senescence starts from the claim that mod

LRRK2 Volume Sensor Hijacking Drives Metabolic Dysregulation via SIRT1/PGC1α Sup

Score: 0.666 · neurodegeneration · 2026-04-16

## Mechanistic Overview LRRK2 Volume Sensor Hijacking Drives Metabolic Dysregulation via SIRT1/PGC1α Suppression starts

Gamma entrainment corrects AD-related clock gene dysregulation to normalize hipp

Score: 0.651 · Alzheimer's disease · 2026-04-28

Alzheimer's pathology disrupts circadian PER1/2 and BMAL1 rhythms in hippocampal neurons. Gamma entrainment, particularl

Endothelial miR-181c-5p Upregulation Drives Claudin-5 Repression and Paracellula

Score: 0.645 · unknown disease · 2026-04-26

Circulating miR-181c-5p is upregulated in AD patients and directly targets the CLDN5 3'-UTR, suppressing claudin-5 expre

Neuronal TET1 Upregulation Reactivates Immediate-Early Genes and Restores Dendri

Score: 0.640 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The hypothesis centers on the ten-eleven translocation 1 (TET1) enzyme's critical

Microglial TREM2 downregulation impairs damage-associated response in late-stage

Score: 0.626 · Alzheimer's disease · 2026-04-04

## Mechanistic Overview Microglial TREM2 downregulation impairs damage-associated response in late-stage Alzheimer's dis

RNA-Binding Protein Sequestration and 3′UTR Dysregulation

Score: 0.625 · unknown disease · 2026-04-26

Intron-retained GBA isoform sequesters neuronal RBPs (FMRP, HuR, TDP-43) that normally bind to wild-type GBA mRNA 3′UTR

Regulation

Understanding Entity Pages

Wiki Pages (18)

Transcriptional Regulation in Neurodegeneration

OTULIN-Tau Regulation Pathway

Cerebral Blood Flow Regulation in Neurodegeneration

PTPσ (PTPRS) in C9ORF72-ALS/FTD - PI3P Regulation Mechanism

Epigenetic Regulation

Autophagy Molecular Regulation in Neurodegeneration

MS4A4A-MS4A6A Cooperation in TREM2 Regulation

Transcription Regulation Pathway

Transcription Regulation in Neurodegenerative Diseases

TREM2 Inflammatory Cytokine Regulation

Raphe Nuclei in Mood Regulation and Neurodegeneration